search
Back to results

Efficacy of Teeth Whitening Product Offerings in Adults

Primary Purpose

Tooth Discoloration

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Hydrogen peroxide teeth whitening gel
GLO Brilliant Teeth Whitening Device
GLO Lit Teeth Whitening Device
GLO Science Professional Teeth Whitening Device
Sponsored by
Glo Science, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tooth Discoloration focused on measuring Teeth whitening, Teeth bleaching, Tooth discoloration

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Provide written informed consent to participate in the study.
  • Be 18 to 65 years of age.
  • Agree not to participate in any other oral/dental product studies during the trial.
  • Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed.
  • Agree to refrain from the use of any other teeth whitening products once assigned to a treatment group.
  • Agree to refrain from the use of any oral care products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).
  • Agree to return for all scheduled visits and follow study procedures.
  • Be in good general health, as determined by the investigator/designee based on a review of the health history/update for participation in the study.
  • Have at least 4 gradable maxillary anterior teeth ( canine to canine) with a Vita Shade average score of C2 or darker.
  • Be willing to refrain from consuming stain-causing food and beverages (i.e., coffee, tea, red wine, berries, etc.) during the initial treatment duration (treatment period excluding the 4 week follow up).
  • Be a current or recent non-smoker (no smoking for at least 3 months).

Exclusion Criteria:

  • Are undergoing treatment for gingivitis, periodontitis, or caries.
  • Presence of self-reported tooth sensitivity.
  • Present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
  • Have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth ( canine to canine) or mandibular anterior teeth.
  • Have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
  • Present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
  • Have meaningful malocclusion that would impact treatment or ease of viewing/scoring maxillary anterior teeth.
  • Have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypocalcification.
  • Have any known allergies to over-the-counter oral hygiene/whitening products.
  • Have any known allergies to the trial product ingredients.
  • Are pregnant and/or breastfeeding.
  • Are current smokers.

Sites / Locations

  • Arizona School of Dentistry & Oral Health

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

GLO Science Professional Chairside Teeth Whitening

GLO Science Professional At-Home Teeth Whitening Device

GLO Brilliant At-Home Teeth Whitening Device

GLO Lit At-Home Teeth Whitening Device

GLO Lit Whitening GLO Vials

Arm Description

Outcomes

Primary Outcome Measures

Tooth whitening efficacy: tooth shade value
Change in tooth shade value as indicated by the digital VITA Easyshade V

Secondary Outcome Measures

Tooth whitening safety: presence/absence of adverse events
Post-treatment dentinal hypersensitivity and the presence/absence of adverse events

Full Information

First Posted
October 10, 2019
Last Updated
February 4, 2020
Sponsor
Glo Science, Inc.
Collaborators
Arizona School of Dentistry & Oral Health, A. T. Still University
search

1. Study Identification

Unique Protocol Identification Number
NCT04124068
Brief Title
Efficacy of Teeth Whitening Product Offerings in Adults
Official Title
Efficacy of GLO Science Professional Teeth Whitening Product Offerings in Adults
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
September 1, 2019 (Actual)
Primary Completion Date
November 30, 2019 (Actual)
Study Completion Date
December 30, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Glo Science, Inc.
Collaborators
Arizona School of Dentistry & Oral Health, A. T. Still University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a 30 day randomized, parallel comparative trial where participants with tooth shade of C2 or darker will be assigned to one of five groups. The participants will be evaluated for the difference in tooth shade, as determined by the digital VITA Easyshade V (provided by GLO) before the respective whitening regimen (baseline), immediately following the treatment period, and at 30 days (~4 weeks) from end of the treatment intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tooth Discoloration
Keywords
Teeth whitening, Teeth bleaching, Tooth discoloration

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
75 (Actual)

8. Arms, Groups, and Interventions

Arm Title
GLO Science Professional Chairside Teeth Whitening
Arm Type
Experimental
Arm Title
GLO Science Professional At-Home Teeth Whitening Device
Arm Type
Experimental
Arm Title
GLO Brilliant At-Home Teeth Whitening Device
Arm Type
Experimental
Arm Title
GLO Lit At-Home Teeth Whitening Device
Arm Type
Experimental
Arm Title
GLO Lit Whitening GLO Vials
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Hydrogen peroxide teeth whitening gel
Intervention Description
Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%
Intervention Type
Device
Intervention Name(s)
GLO Brilliant Teeth Whitening Device
Intervention Description
Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
Intervention Type
Device
Intervention Name(s)
GLO Lit Teeth Whitening Device
Intervention Description
Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
Intervention Type
Device
Intervention Name(s)
GLO Science Professional Teeth Whitening Device
Intervention Description
Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
Primary Outcome Measure Information:
Title
Tooth whitening efficacy: tooth shade value
Description
Change in tooth shade value as indicated by the digital VITA Easyshade V
Time Frame
Immediately following treatment period (32 minutes, 5 days or 7 days), and after 30 days
Secondary Outcome Measure Information:
Title
Tooth whitening safety: presence/absence of adverse events
Description
Post-treatment dentinal hypersensitivity and the presence/absence of adverse events
Time Frame
Immediately following treatment period (32 minutes, 5 days or 7 days), and after 30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Provide written informed consent to participate in the study. Be 18 to 65 years of age. Agree not to participate in any other oral/dental product studies during the trial. Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed. Agree to refrain from the use of any other teeth whitening products once assigned to a treatment group. Agree to refrain from the use of any oral care products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.). Agree to return for all scheduled visits and follow study procedures. Be in good general health, as determined by the investigator/designee based on a review of the health history/update for participation in the study. Have at least 4 gradable maxillary anterior teeth ( canine to canine) with a Vita Shade average score of C2 or darker. Be willing to refrain from consuming stain-causing food and beverages (i.e., coffee, tea, red wine, berries, etc.) during the initial treatment duration (treatment period excluding the 4 week follow up). Be a current or recent non-smoker (no smoking for at least 3 months). Exclusion Criteria: Are undergoing treatment for gingivitis, periodontitis, or caries. Presence of self-reported tooth sensitivity. Present with fixed orthodontic appliances on the facial surfaces of the maxillary arch. Have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth ( canine to canine) or mandibular anterior teeth. Have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised. Present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation. Have meaningful malocclusion that would impact treatment or ease of viewing/scoring maxillary anterior teeth. Have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypocalcification. Have any known allergies to over-the-counter oral hygiene/whitening products. Have any known allergies to the trial product ingredients. Are pregnant and/or breastfeeding. Are current smokers.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ann Spolarich, RDH, PhD
Organizational Affiliation
Arizona School of Dentistry & Oral Health, A. T. Still University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Arizona School of Dentistry & Oral Health
City
Mesa
State/Province
Arizona
ZIP/Postal Code
85206
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy of Teeth Whitening Product Offerings in Adults

We'll reach out to this number within 24 hrs